Somerset, NJ, United States of America

Carl LeBlond


Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1999-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Carl LeBlond: Innovator in Catalytic Processes

Introduction

Carl LeBlond is a notable inventor based in Somerset, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of catalytic processes. With a total of 3 patents to his name, LeBlond's work has had a considerable impact on various chemical reactions.

Latest Patents

LeBlond's latest patents include innovative processes that enhance chemical reactions. One of his notable inventions is a heterogeneously catalyzed process for cross-coupling alkenyl halides with boronic acids. This process utilizes finely-dispersed palladium catalysts in a cross-coupling reaction, producing aryl- or heteroaryl-olefin compounds. Another significant patent is related to a stereoselective process for enalapril, which improves the catalytic reductive amination between ethyl 2-oxo-4-phenylbutyrate and alanylproline. This invention aims to produce the ACE inhibitor, enalapril, using hydrogen, a catalyst, and various additives.

Career Highlights

Carl LeBlond is currently associated with Merck & Company, Inc., where he continues to innovate and contribute to the field of pharmaceuticals. His work at Merck has allowed him to explore various chemical processes and develop new methodologies that enhance drug development.

Collaborations

Throughout his career, LeBlond has collaborated with esteemed colleagues, including Yongkui Sun and John R Sowa, Jr. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Carl LeBlond is a distinguished inventor whose work in catalytic processes has made a significant impact on the field of chemistry. His contributions continue to influence the development of new pharmaceuticals and chemical methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…